Sharp Therapeutics Corp.
SHRX.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | -1.09M | 559.10K | -3.25M | -679.60K | |
| Total Depreciation and Amortization | 25.20K | 23.00K | 26.90K | 4.40K | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 74.30K | -1.95M | 1.99M | 15.20K | |
| Change in Net Operating Assets | -132.60K | 24.60K | -152.60K | -210.30K | |
| Cash from Operations | -1.12M | -1.35M | -1.39M | -870.40K | |
| Capital Expenditure | -- | -- | -- | 0.00 | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | -- | -- | |
| Cash from Investing | -- | -- | -- | 0.00 | |
| Total Debt Issued | -- | -- | -- | 950.00K | |
| Total Debt Repaid | -50.00K | -50.00K | -50.00K | -50.00K | |
| Issuance of Common Stock | 6.60K | 2.48M | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -500.00K | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -400.00K | |
| Cash from Financing | -43.40K | 2.43M | -50.00K | 0.00 | |
| Foreign Exchange rate Adjustments | 5.10K | 45.90K | -26.00K | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | 900.00K | |
| Net Change in Cash | -1.16M | 1.13M | -1.47M | 29.60K | |